WHY IT MATTERS: If you are replacing alcohol with THC-containing cannabis products under the assumption that it is automatically the safer choice, speak with a knowledgeable clinician first, because that assumption is not supported by current evidence for everyone. CLINICAL OVERVIEW: As alcohol consumption declines among Americans, cannabis and THC products are increasingly filling that behavioral and social role, raising legitimate questions about whether this represents a genuine health improvement or simply a substitution of one psychoactive substance for another. THC carries its own risk profile, including effects on cognition, cardiovascular function, respiratory health when smoked, and mental health vulnerability in predisposed individuals.
Teen Marijuana Use Doubles Chances of Future Psychotic Disorders, Study Finds
WHY IT MATTERS: Parents and adolescent patients should understand that the psychiatric risks associated with cannabis use before age 18 are biologically distinct from adult-onset use, and delaying initiation until adulthood is one of the most evidence-supported harm reduction strategies available. CLINICAL OVERVIEW: Research examining adolescent cannabis use has consistently identified a meaningful association between early initiation and elevated risk for psychotic spectrum disorders in adulthood, with the biological vulnerability of the developing adolescent brain playing a central role in this relationship. The endocannabinoid system undergoes significant maturation throughout adolescence, and exogenous cannabinoids introduced during this window appear to disrupt neurodevelopmental trajectories in ways that can have lasting psychiatric consequences.
In the Mix: 10 More Articles — February 25, 2026
10 cannabis articles reviewed and scored below the CED clinical relevance threshold in the February 25, 2026 feed update. Summaries and source links included.
Extended moratorium on Oklahoma medical marijuana business licenses approved by House
WHY IT MATTERS: Oklahoma medical cannabis patients may see shifts in dispensary availability and product selection as licensing freezes and cultivation limits reshape which businesses can survive in an already competitive market. CLINICAL OVERVIEW: Oklahoma has been one of the most permissive states for medical cannabis licensing, resulting in a densely saturated market that has created significant regulatory and quality control challenges. Legislative efforts to extend moratoriums on new business licenses and cap cultivation operations reflect an attempt to bring structure to an industry that expanded faster than oversight mechanisms could follow.
Medical and recreational marijuana bills introduced in Kansas Legislature – KAKE
WHY IT MATTERS: If Kansas passes medical cannabis legislation, patients currently traveling to neighboring states or going without treatment may soon be able to access cannabis-based therapies legally and closer to home. CLINICAL OVERVIEW: Kansas is considering legislation that would establish both medical and recreational cannabis frameworks, representing a significant shift for one of the few remaining states with no legal cannabis access. The medical proposals include pathways for patients with qualifying conditions to access cannabis-based treatments under physician supervision, while rescheduling efforts at the federal level have created new momentum for states like Kansas to act.
Legislation on medical cannabis: DOH bares conditions – Cebu Daily News
WHY IT MATTERS: Filipino patients with conditions like chronic pain, epilepsy, or cancer-related symptoms may soon have a clearer legal pathway to access medical cannabis, but only if proposed legislation meets the scientific standards regulators are demanding. CLINICAL OVERVIEW: Medical cannabis legislation in the Philippines is advancing through regulatory channels, with health authorities emphasizing that any framework for legal access must be grounded in robust clinical and scientific evidence. This position reflects a cautious but scientifically oriented approach to policy, requiring that efficacy and safety data drive decisions rather than anecdotal reports or political pressure.
House panel revives medical cannabis bill – Daily Tribune
WHY IT MATTERS: Patients in the Philippines with conditions like epilepsy, chronic pain, or cancer-related symptoms who currently have no legal access to cannabinoid therapies may gain a regulated pathway to these treatments if this bill advances to full legislative approval and enactment. CLINICAL OVERVIEW: The Philippines is advancing legislation to permit medical cannabis, with House committees on health and dangerous drugs giving approval to a consolidated bill that would establish a regulated framework for therapeutic use. This represents a significant shift in a country that has historically maintained strict anti-drug policies, including severe penalties under the Comprehensive Dangerous Drugs Act.
House panel approves proposed medical cannabis law – POLITIKO
WHY IT MATTERS: If this medical cannabis law passes in the Philippines, patients with qualifying conditions may gain legal access to cannabis-based treatments that were previously unavailable or carried serious legal risk. CLINICAL OVERVIEW: The Philippine House of Representatives has moved forward with proposed legislation that would formalize a medical cannabis framework, focusing on expanding research infrastructure and creating regulated pathways for patient access. This represents a significant shift in drug policy for a country that has historically maintained strict prohibitionist stances toward cannabis.
Bill to protect Nebraska physicians recommending medical cannabis advances to floor
WHY IT MATTERS: If this bill passes, Nebraska patients will have a much better chance of finding a licensed physician willing to openly discuss and recommend medical cannabis without fear of losing their medical license. CLINICAL OVERVIEW: Physician protection legislation in Nebraska addresses a longstanding barrier to medical cannabis access: the fear among doctors that recommending cannabis could expose them to professional or legal consequences under state licensing boards. Without such protections, many qualified physicians avoid cannabis consultations entirely, leaving patients without informed medical guidance even in states where the therapy is legal.
Observational study on medical marijuana use seeks Arizona participants – KJZZ
WHY IT MATTERS: Arizona adults who are about to start using cannabis for a medical condition have a time-sensitive opportunity to contribute to national research that could directly shape how physicians recommend and dose cannabis for patients like them. CLINICAL OVERVIEW: Observational research on medical cannabis is essential for building the real-world evidence base that controlled trials alone cannot provide, particularly given the diversity of conditions, products, and consumption patterns patients bring to clinical settings. Recruiting participants at the point of initiation allows researchers to capture baseline data and track outcomes longitudinally, which strengthens the quality of findings compared to studies that enroll patients already well into their cannabis use.